Evidence map›Paper›PMID 28842749›Full record

ReviewSeminars in immunopathology2018

Complement as a regulator of adaptive immunity.

Justin Killick, Gregoire Morisse, Dirk Sieger, Anne L Astier

Open access · hybridAbstract readReview
In one paragraph

Review in Seminars in immunopathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 122 citations in OpenAlex.

  1. Adaptive Immunity in Marsupials.Journal of experimental zoology. Part A, Ecological and integrative physiology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The multiverse of CD46 and oncologic interactions.The Journal of clinical investigation · 2025
    Review
  10. Article
  11. Article
  12. Exosomal-complement system activation in preeclampsia.The journal of obstetrics and gynaecology research · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Role of Complement in Liver Diseases.Seminars in liver disease · 2024
    Review
  17. Immunity and Coagulation in COVID-19.International journal of molecular sciences · 2024
    Review
  18. Article
  19. Review
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Justin KillickMRC Centre for Inflammation Research, Edinburgh Centre for MS Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, EH16 4TJ, UK.
Gregoire MorisseMRC Centre for Inflammation Research, Edinburgh Centre for MS Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, EH16 4TJ, UK.
Dirk SiegerCentre for NeuroRegeneration, Edinburgh Centre for MS Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.
Anne L AstierMRC Centre for Inflammation Research, Edinburgh Centre for MS Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, EH16 4TJ, UK. anne.astier@inserm.fr.ORCID 0000-0002-0144-3431
Centre for Inflammation Research · GBCentre National de la Recherche Scientifique · FRUniversity of Edinburgh · GB

Funding

Cancer Research UK 17494Multiple Sclerosis Society 34Multiple Sclerosis Society 41
6 · The paper itself

Abstract

The complement system is an ancient and evolutionarily conserved effector system comprising in mammals over 50 circulating and membrane bound proteins. Complement has long been described as belonging to the innate immune system; however, a number of recent studies have demonstrated its key role in the modulation of the adaptive immune response. This review does not set out to be an exhaustive list of the numerous interactions of the many complement components with adaptive immunity; rather, we will focus more precisely on the role of some complement molecules in the regulation of antigen presenting cells, as well as on their direct effect on the activation of the core adaptive immune cells, B and T lymphocytes. Recent reports on the local production and activation of complement proteins also suggest a major role in the control of effector responses. The crucial role of complement in adaptive immunity is further highlighted by several examples of dysregulation of these pathways in human diseases.

Indexed as

Adaptive ImmunityComplement ActivationAnimalsAntigen-Presenting CellsB-LymphocytesCarrier ProteinsCell CommunicationComplement System ProteinsDisease SusceptibilityHumansImmunologic FactorsImmunomodulationLymphocyte ActivationMolecular Targeted TherapyProtein BindingSignal TransductionCarrier ProteinsComplement System ProteinsImmunologic FactorsAdaptive immunityB cellsCD46ComplementInflammationT cells

Identifiers

PMID28842749
PMCPMC5794818
OpenAlexW2748098899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.